171 related articles for article (PubMed ID: 6093897)
21. Purification and characterization of the specific binding protein for platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from human platelets.
Nishihira J; Ishibashi T; Imai Y; Muramatsu T
Tohoku J Exp Med; 1985 Oct; 147(2):145-52. PubMed ID: 3001971
[TBL] [Abstract][Full Text] [Related]
22. Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes.
Hwang SB; Lee CS; Cheah MJ; Shen TY
Biochemistry; 1983 Sep; 22(20):4756-63. PubMed ID: 6313047
[TBL] [Abstract][Full Text] [Related]
23. Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.
Kloprogge E; Akkerman JW
Biochem J; 1984 Nov; 223(3):901-9. PubMed ID: 6150705
[TBL] [Abstract][Full Text] [Related]
24. Platelet-activating factor (PAF) increase intracellular lipid accumulation by increasing both LDL and scavenger receptors in human mesangial cells.
Fragopoulou E; Iatrou C; Antonopoulou S; Ruan XZ; Fernando RL; Powis SH; Moorhead JF; Varghese Z
J Lab Clin Med; 2006 Jun; 147(6):281-9. PubMed ID: 16750665
[TBL] [Abstract][Full Text] [Related]
25. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of interaction of a plasmalogenic analog of platelet-activating factor with human platelets.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 1999 Jun; 64(6):631-5. PubMed ID: 10395976
[TBL] [Abstract][Full Text] [Related]
27. Occupancy of platelet receptors for platelet-activating factor in asthmatic patients during an allergen-induced bronchoconstrictive reaction.
Burgers JA; Bruynzeel PL; Mengelers HJ; Kreukniet J; Akkerman JW
J Lipid Mediat; 1993 Jun; 7(2):135-49. PubMed ID: 8400115
[TBL] [Abstract][Full Text] [Related]
28. Human plasma platelet-activating factor acetylhydrolase. Purification and properties.
Stafforini DM; Prescott SM; McIntyre TM
J Biol Chem; 1987 Mar; 262(9):4223-30. PubMed ID: 3558407
[TBL] [Abstract][Full Text] [Related]
29. Specific binding of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) to the intact canine platelet.
Janero DR; Burghardt B; Burghardt C
Thromb Res; 1988 Jun; 50(6):789-802. PubMed ID: 3413730
[TBL] [Abstract][Full Text] [Related]
30. Impairment of endothelium-dependent aorta relaxation by phospholipid components of oxidized low-density lipoprotein.
Vasques E; Almeida AL; Noya V; D'Alegria B; Marathe G; McIntyre TM; Tibiriçá E; Bozza PT; Silva AR; Castro-Faria-Neto HC
Endothelium; 2006; 13(1):1-8. PubMed ID: 16885061
[TBL] [Abstract][Full Text] [Related]
31. PAF binding to a single receptor in corneal epithelium plasma membrane.
Hurst J; Ma X; Bazan HE
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):790-5. PubMed ID: 10067986
[TBL] [Abstract][Full Text] [Related]
32. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced fibrinogen binding to human platelets.
Kloprogge E; Mommersteeg M; Akkerman JW
J Biol Chem; 1986 Aug; 261(24):11071-6. PubMed ID: 3015954
[TBL] [Abstract][Full Text] [Related]
34. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes.
Tokumura A; Tsutsumi T; Yoshida J; Tsukatani H
Biochim Biophys Acta; 1990 May; 1044(1):91-100. PubMed ID: 2340312
[TBL] [Abstract][Full Text] [Related]
35. [Metabolism of lipoproteins: role of specific receptors].
Mathé D; Guettet C; Lecuyer B; Jacotot B
Journ Annu Diabetol Hotel Dieu; 1987; ():7-21. PubMed ID: 3039230
[No Abstract] [Full Text] [Related]
36. Binding and internalization of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in washed rabbit platelets.
Homma H; Tokumura A; Hanahan DJ
J Biol Chem; 1987 Aug; 262(22):10582-7. PubMed ID: 3038889
[TBL] [Abstract][Full Text] [Related]
37. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme.
Min JH; Wilder C; Aoki J; Arai H; Inoue K; Paul L; Gelb MH
Biochemistry; 2001 Apr; 40(15):4539-49. PubMed ID: 11294621
[TBL] [Abstract][Full Text] [Related]
38. The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease).
Pritchard PH; Chonn A; Yeung CC
Blood; 1985 Dec; 66(6):1476-8. PubMed ID: 4063532
[TBL] [Abstract][Full Text] [Related]
39. Photoaffinity labeling of platelet activating factor binding sites in rabbit platelet membranes.
Chau LY; Tsai YM; Cheng JR
Biochem Biophys Res Commun; 1989 Jun; 161(3):1070-6. PubMed ID: 2545193
[TBL] [Abstract][Full Text] [Related]
40. Estimation of platelet-activating factor receptors in the endometrium of the pregnant rabbit: regulation of ligand availability and catabolism by bovine serum albumin.
Kudolo GB; Harper MJ
Biol Reprod; 1990 Sep; 43(3):368-77. PubMed ID: 1703022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
